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The concept of anhedonia
nhedonia refers to the reduced ability to expe-
rience pleasure.
1 It has had an important place in many
aspects of psychopathology since it was first described in
the previous century,
2 and is still a feature of several types
of psychiatric disorders and maladaptive behaviors.
3-5
Anhedonia has been the most extensively studied in
major depression,
6 but,as it also constitutes one impor-
tant negative symptom of schizophrenia,much literature
has also been devoted to anhedonia in psychosis.
3,7
Anhedonia has in fact been studied in a large range of
neuropsychiatric disorders,including substance use dis-
order,
8-10 Parkinson's disease,
11 overeating,
12 and various
risky behaviors.
13
Anhedonia is nevertheless considered to be a core fea-
ture of major depressive disorder as, for example, the
Diagnostic and Statistical Manual of Mental Disorders,
Fourth edition (DSM-IV)
14 requires that either depressed
mood or anhedonia be present to propose this diagnosis.
Furthermore, lack of reactivity and anhedonia are key
diagnostic criteria for the DSM-IV melancholic subtype
of major depression,
14 and presence of anhedonia has
been shown to be predictive of antidepressant response.
15
The absence of diagnostic specificity could be regarded
as a limiting factor when trying to define anhedonia as
a pivotal feature of major depressive disorder.The devel-
opment of the “endophenotype” concept may help to
overtake such limits, on the basis of three notions.
16
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Anhedonia refers to the reduced ability to experience
pleasure, and has been studied in different neuropsychi-
atric disorders. Anhedonia is nevertheless considered as a
core feature of major depressive disorder, according to
DSM-IV criteria for major depression and the definition of
melancholic subtype, and regarding its capacity to predict
antidepressant response. Behavioral, electrophysiological,
hemodynamic, and interview-based measures and self-
reports have been used to assess anhedonia, but the most
interesting findings concern neuropharmacological and
neuroanatomical studies. The analyses of anhedonic non-
clinical subjects, nonanhedonic depressed patients, and
depressed patients with various levels of anhedonia seem
to favor the hypothesis that the severity of anhedonia is
associated with a deficit of activity of the ventral striatum
(including the nucleus accumbens) and an excess of activ-
ity of ventral region of the prefrontal cortex (including the
ventromedial prefrontal cortex and the orbitofrontal cor-
tex), with a pivotal, but not exclusive, role of dopamine.   
© 2008, LLS SAS Dialogues Clin Neurosci. 2008;10:291-299.Patients with psychiatric disorders could differ from
healthy individuals quantitatively more than qualita-
tively.Furthermore,the detected disorder could be more
extensively understood if the genetic and environmental
risk factors are being related to the disorder through
intermediate phenotypes.Lastly,endophenotypes might
be unspecific,being based on abnormal neurobiological
mechanisms that can be shared by various psychiatric dis-
orders,these usually being defined as complex,polyfac-
torial disorders.
These endophenotypes,involving more directly the neu-
robiological and neuropsychological aspects of the dis-
ease, could help to link the potential risk factors more
directly to major depression (Figure 1).There are differ-
ent required qualities to use a trait as an endophenotype,
such as sensitivity and specificity,heritability,presence in
unaffected relatives,state-independence,biological plau-
sibility, sound psychometric properties, and feasibility.
Even if there are practically no endophenotypes meeting
all these criteria,the biological plausibility of anhedonia
in major depressive disorder is the matter of this review,
and the first required quality to constitute a valid
endophenotype is the validity of its assessment.
Assessing anhedonia
An emotion involves physiologic arousal,appraisal,sub-
jective experience,expression,and goal-directed behav-
ior.
17Anhedonia can therefore be measured in various
ways (for an extensive review see Franken et al
18).
Behavioral,
19 electrophysiological,
20 hemodynamic,
21
interview-based measures,
22 and self-reports are cited in
research devoted to anhedonia in major depressive dis-
order (MDD). For example, depressed patients show
higher sweet taste perception thresholds in response to
sucrose solutions,
23 with significantly reduced reward
responsiveness,partly because of difficulty in integrating
reinforcement history over time.
24
Rewards serve to elicit approach and consummatory
behaviors, increase the frequency and intensity of the
behaviors,maintain the behaviors,prevent their extinction,
and induce subjective feelings of pleasure or positive emo-
tional states.
25 Reward is therefore a key concept in assess-
ing anhedonia, and the basis of the majority of animal
studies devoted to its neurobiological mechanisms.
Self-questionnaires have been more frequently used in
clinical practice and research,for obvious reasons of sim-
plicity.Various instruments are available,including the
61-item instrument Chapman Physical Anhedonia Scale
the (PAS)
22 and its revised form, the Revised Physical
Anhedonia Scale (R-PAS),
28 the Fawcett-Clark Pleasure
Scale (FCPS),
27 and the Snaith-Hamilton Pleasure Scale
(SHPS or SHAPS).
18,28These instruments all assess hedo-
nic capacity (see for example Table I),but their psycho-
metric properties,and frequently their analyzed dimen-
sions,are different.
29 Nevertheless,the predictive validity
of these instruments seems to be good;for example,indi-
viduals with higher scores on self-report measures of
anhedonia report lower hedonic responses to emotion-
eliciting pictures,
30 positive emotional scripts,
31 and
sucrose solutions,
23 and are less responsive on measures
of heart rate and facial expressions in response to emo-
tion-eliciting slides.
30
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Figure 1. The role of anhedonia as an intermediate phenotype (endophe-
notype) between the involved risk factors and depression.
Vulnerability genes
Abnormal reward process
Anhedonia
Major depressive disorder
Environmental risk factors
1. I would enjoy my favourite television or radio programme
2. I would enjoy being with family or close friends
3. I would find pleasure in my hobbies and pastimes
4. I would be able to enjoy my favourite meal
5. I would enjoy a warm bath or refreshing shower
6. I would find pleasure in the scent of flowers or the smell of a 
fresh sea breeze or freshly baked bread
7. I would enjoy seeing other people's smiling faces
8. I would enjoy looking smart when I have made an effort with 
my appearance
9. I would enjoy reading a book magazine or newspaper
10. I would enjoy a cup of tea or coffee or my favourite drink
11. I would find pleasure in small things e.g. bright sunny day a 
telephone call from a friend
12. I would be able to enjoy a beautiful landscape or view
13. I would get pleasure from helping others
14. I would feel pleasure when I receive praise from other people
Table I. Items of the Snaith-Hamilton Pleasure Scale.
28Neural basis of normal positive 
emotion perception
As previously described in detail,
32 feeling a normal emo-
tion requires the identification of the emotional signifi-
cance of a stimulus (appraisal),then the production of an
affective state (production),which can be regulated at
different levels (regulation). These three steps can be
considered as being organized through two different sys-
tems,with a reciprocal functional relationship.
A ventral system (including the amygdala,insula,ventral
striatum, and ventral regions of the anterior cingulate
gyrus and prefrontal cortex),could be more specifically
involved in the identification of the emotional signifi-
cance of environmental stimuli, and the production of
affective states.This system could also be in charge of
automatic regulation and mediation of autonomic
responses to emotive stimuli and contexts accompanying
the production of affective states.
A dorsal system (including the hippocampus and dorsal
regions of the anterior cingulate gyrus and prefrontal cor-
tex), on the other hand, could be more important for
effortful rather than automatic regulation of affective
states,probably through executive functions,including
selective attention and planning.
The basis of hedonic feelings has been more specifically
studied through different paradigms.Euphoric response
to dextroamphetamine,
33 cocaine-induced euphoria,
34
monetary reward,
35,36 and even pleasurable responses to
music,
37 pictures,
38 and attractive faces,
39 have been asso-
ciated with activity within the nucleus accumbens,ven-
tral caudate,and ventral putamen,and,in studies devoted
to the neurobiology of pleasure,with dopamine release
in the ventral caudate and putamen.
The ventral striatum,and particularly the nucleus accum-
bens,
40 may indeed have a priority role according to stud-
ies in both animals and humans,in behavioral responses
to,anticipation of,and/or monitoring of errors in the pre-
diction of reward.
41,42The nucleus accumbens appears to
respond to the emotional intensity and self-relatedness
of a variety of stimuli,independent of their valence,
43 with
both positive and negative valences possibly processed
along a rostrocaudal gradient.
44The nucleus accumbens
receives projections from midbrain regions (such as the
ventral tegmental area),from regions involved in emo-
tion (such as the amygdala, orbitofrontal cortex, and
medial prefrontal cortex),from motor regions (such as
the dorsal caudate and globus pallidus),and from regions
involved in memory (such as the hippocampus).
45 The
accumbens also indirectly projects to cortical regions
including the cingular and medial prefrontal cortex,the
ventral pallidum, the thalamus, the amygdala, and the
hypothalamus.
46-48 Many of these regions are also impli-
cated in emotion processing, suggesting a network of
tightly anatomically and functionally connected regions.
49
The orbitofrontal cortex is a nexus for sensory integration,
the modulation of autonomic reactions,and anticipation
in learning,prediction and decision-making for emotional
and reward-related behaviours.
50 Neuroimaging studies
have found that the reward value,
51 and the expected
reward value,
52 and even the subjective pleasantness of
food
53 and other reinforcers are represented in the
orbitofrontal cortex. The orbitofrontal cortex receives
input from the five classic sensory modalities:gustatory,
olfactory,somatosensory,auditory,and visual,
54 and also
receives visceral sensory information.This large variety of
inputs makes the orbitofrontal cortex one of the most
polymodal regions in the entire cortical mantle.
53 The
orbitofrontal cortex has direct reciprocal connections with
other brain structures,including the amygdala,cingulate
cortex, insula/operculum, hypothalamus, hippocampus,
striatum,periaqueductal grey,and dorsolateral prefrontal
cortex. Hence, the orbitofrontal cortex may have an
important role for representing incentive salience,hedo-
nic impact,and subjective hedonic experience,ie,consti-
tuting the link between reward and hedonic experience.
53
It has been shown that the human amygdala is a key
structure for extracting the affective significance from
external stimuli,
55 responds preferentially to emotionally
valenced faces,for fearful but also for happy faces,and
rapidly habituates to them.
56 According to discrepant
findings,
57,58 the amygdala could be considered as react-
ing more intensively for negative stimuli,explaining its
major function in fear and anxiety.
The anterior cingular cortex was not activated by tran-
sient happiness induced by recalling positive life events
and looking at happy human faces.
59 On the other hand,
individual differences in the ability to accurately detect
emotional signals,interoceptively or exteroceptively,may
be at least in part a function of the degree to which the
anterior cingulate cortex participates in the experiential
processing and response to emotion cues.
60
The ventromedial prefrontal cortex (VMPFC) has been
implicated
21 in the generation of an abstract representa-
tion of the rewarding value of a stimulus by attending to
its context,
61 and the learning of contingencies based on
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35 By contrast,lat-
eral areas of the ventral prefrontal cortex may be less
involved in hedonic emotions, responding to aversive
rather than rewarding stimuli.
62,63
Some other regions might have a more obvious role in
negative and/or distressing emotions rather than hedo-
nic experiences,such as the insula.
64,65 Recall-generated
sadness was associated with significantly greater
increases in activity in the vicinity of the anterior insular
cortex,suggesting that this region participates in the emo-
tional response to potentially distressing cognitive or
interoceptive sensory stimuli.
Neuropharmacology of anhedonia in major
depressive disorder
There is considerable evidence that dopamine has a core
role in the brain reward system.
66 Indeed, dopamine is
released in animal models of behaviors that involve the
brain reward system such as food intake or expectation,
sex, and drug self-administration. More precisely,
dopamine release from the nucleus accumbens,during
exposure to a novel food,is modulated by various char-
acteristics of the stimulus and motivational state.
67
Accordingly,dopamine D2 receptor blockers inhibit drug
self-administration and conditioned place preference
with psychostimulants,while a D2 agonist is self-admin-
istered in monkeys.
68 Dopamine release in the nucleus
accumbens may underlie approach responses and guid-
ance towards positive incentives (ie,motivation).
69 It has
been alternatively proposed that dopamine does not
mediate reinforcement directly,but instead constitutes a
higher-order sensorimotor integrator,relating primary
reinforcers (such as palatable food) and response initia-
tion,maintenance and selection,
70 therefore stressing the
concepts of “wanting”instead of “liking.”
71 Others argue
that neurons from the mesocorticolimbic dopamine path-
way are serving to induce approach behaviors for con-
sumption, positive reinforcement, and learning, all of
which lead the organism to adapt to the environment.
Interestingly,dopamine neurons do not predict aversive
stimuli like pain,
72 showing that dopamine is relatively
specific for the detection of potentially rewarded stimuli.
When confronting neuropharmacology with neu-
roanatomy, it was shown that primary rewards increase
dopamine release, mainly in the shell of the nucleus
accumbens,whereas secondary rewards increase it in the
medial prefrontal cortex and nucleus accumbens core.This
distinction might be important for anhedonia in major
depressive disorder,as both processes could be involved,
either decreased feelings of rewards (due a to reduced
dopamine firing in the shell) or abnormal capacity to dis-
tinguish the incentive value of a conditioned appetitive
stimulus (due to reduced dopamine firing in the medial
prefrontal cortex and the core of the nucleus accumbens).
The essential role of dopamine in the brain reward sys-
tem does not mean that it has an independent role,nor
does it imply that dopamine is the final common pathway
to getting the reward effect. For example, the nucleus
accumbens contains opioid receptors which also mediate
reward.
73 Opioid antagonists decrease reward behavior,
74
and block the stimulation of dopamine release in the
nucleus accumbens shell when exposed to various drugs
and palatable food,
75 and could directly modulate sexual
motivation.
76
Glutamate also has a significant role in the reward sys-
tem,for example via the subiculum,a hippocampal struc-
ture containing glutamatergic neurons,that projects to
the nucleus accumbens.
77Accordingly,N-methyl-D-aspar-
tic acid (NMDA) produces conditioned place preference
in rats,an effect which is reversed by a NMDA antago-
nist.
78The activation of NMDA may be more specifically
responsible for shortening the reaction time for the
responses to stimuli predictive of reward.
79
Serotonin has a recognized effect on the modulation of
dopamine and opioid release,
80 and therefore could have
a regulatory role in the reward process. For example,
serotonin reuptake inhibitors raise the threshold for
brain stimulation reward,
81 and reduce firing rate of
dopamine neurons in the ventral tegmental area.
82
The above list of neurotransmitters potentially involved
in hedonic capacity is not exhaustive, as, for example,
acetylcholine and cholecystokynin also modulate gluta-
mate and dopamine release,and thus participate in the
modulation of the related behaviors or emotions.
83,84
Neural basis of trait anhedonia 
in nondepressed subjects
Assessing a normal range of individual differences
regarding hedonic capacity in front of a set of pictures
with positive valence,Harvey et al
85 found that trait anhe-
donia severity was negatively correlated with the volume
of the anterior caudate and ventral striatum, and was
positively correlated with the activity of the VMPFC for
the processing of positive information.
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reward system, showing the importance of the ventral
striatum in reward behaviors and pleasurable experiences,
in accordance with other studies.
86,87 The VMPFC is
involved in the cognitive aspects of emotional process-
ing.
88,89 It is proposed that VMPFC activity could reflect a
cortical compensatory mechanism for an underactive sub-
cortical/striatal response to pleasant stimuli.
21,85The liter-
ature supports the idea that the VMPFC not only moni-
tors the rewarding value of stimuli/responses, but also
represents one’s upcoming emotional states/reactions.
90
An alternative explanation for an overactive VMPFC in
trait anhedonia could be that this region inhibits emo-
tional processing performed by other limbic structures,
which in turn would lead to reduced emotional experi-
encing.VMPFC activation in anhedonic nonclinical indi-
viduals would therefore reflect such corticolimbic
inhibitory process, more or less specific to positively
valenced stimuli.
85
Specifically assessing the neural basis of anhedonia in
depression is challenging,as anhedonia and mood disor-
ders constitute entangled but not equivalent concepts,
frequently difficult to distinguish.
Neural basis of anhedonia 
in major depressive disorder
Studies of depressed patients
32 have demonstrated
reduced density (number of glial cells) and volume (in
structural neuroimaging studies),but increased activity
(for functional neuroimaging approaches) of regions
involved in the identification of emotional stimuli and the
generation of emotional behavior.In the opposite way,
decreased activity of regions involved in the effortful reg-
ulation of emotional behavior is observed.The subgen-
ual cingulate gyrus,the ventrolateral prefrontal cortex,
the amygdala,the anterior insula,the ventral striatum,
and the thalamus therefore have relative increased activ-
ity (when corrected for volume reduction), while a
decrease in activity is observed in the dorsomedial and
the dorsolateral prefrontal cortices.Interestingly,this pat-
tern of activity reverses after recovery from a major
depressive episode.
91 Such modifications concern both
positive and negative emotions,and hence are not spe-
cific to the capacity to recognize and feel pleasant emo-
tions,ie,anhedonia.Pleasant and unpleasant emotions
could represent opposite ends of a pleasure continuum,
or alternatively,the two motivational systems could be
independent of one another.
91 Some structures might be
equally solicited for pleasant and unpleasant emotions
92
(such as the thalamus, hypothalamus, midbrain, and
medial prefrontal cortex) but others may not.
The role of the amygdala is a heuristic example of the rel-
ative specificity of one neuroanatomical structure in
anhedonia.Decreased volume of the amygdala may par-
ticipate in the restricted emotional range observed in
anhedonic depressed patients (because of the secondary
reduced capacity to prioritize emotional valence of stim-
uli), whereas relative hyperactivity of the amygdala
would favor a bias toward the perception of negative
emotions (because the amygdala may globally react
more intensively for negative stimuli).
Negative correlations were reported between anhedonia
severity and response in subcortical regions,including the
ventral striatum (and thus the nucleus accumbens),in a
neuroimaging study specifically analyzing anhedonia in
depressed individuals engaged in a cognitive task.
93This
result is in accordance with three other studies showing:
(i) a correlation between a psychomotor-anhedonia
symptom cluster and lower metabolism in the anteroven-
tral caudate/putamen in depressed subjects
94;(ii) the lack
of linear increase in right putamen response to facial
expressions of increasing happiness observed in
depressed patients compared with healthy comparison
subjects
95;and (iii) negative correlations between anhe-
donia and activity in larger areas of the striatum in
depressed patients.
21 In other words, patients with the
smallest amount of ventral striatal activation report the
least interest and pleasure in, and subsequent perfor-
mance of activities.It has been proposed that the paucity
of ventral striatal activation observed in depressed
patients may relate more to the translation of motiva-
tional information into behavior than to affective evalu-
ation or encoding per se,which is consistent with a model
of the nucleus accumbens as the limbic-motor inter-
face.
93,96 Individuals with MDD may have supersensitive
behavioral and pharmacological responses to d-amphet-
amine compared with controls.
97,98 This hypersensitive
response correlated with the severity of anhedonic symp-
toms,providing further support for the involvement of
the brain reward system,and dopamine,in major depres-
sive disorder.The role of the nucleus accumbens is so
widely accepted in anhedonia as a pivotal concept of
major depressive disorder,that deep brain stimulation
was recently proposed to three patients in order to alle-
viate anhedonia in severe refractory major depression.
99
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severity and VMPFC activity.
93The response to pleasant
stimuli was also associated with an increased VMPFC
response in depressed individuals.
100,101 In another study
analyzing patients with MDD and variable level of anhe-
donia,
21 positive correlations were found between
responses to happy stimuli and activity in a larger area of
the VMPFC (extending to the anterior cingulate and the
orbitofrontal cortex).
21 The increased and decreased
responses of VMPFC to happy and sad stimuli respec-
tively in MDD, compared with neutral stimuli, but a
reversed pattern of response in healthy volunteers,led to
the interpretation that the increased activity of the
VMPFC in anhedonic depressed patients is because they
are attending more closely to happy stimuli,in an unsuc-
cessful attempt to get into a happy mood.
21
It might be somewhat artificial to describe the potential
role of each brain region when depicting the organization
of anhedonia,although for reasons of clarity it is difficult
to avoid,considering the close relationships linking these
areas.For example,the dissociation of function between
the VMPFC and striatum in response to happy stimuli,in
anhedonically depressed individuals, needs to take into
account their reciprocal connections.The “hypofrontality”
hypothesis of depression suggests that the primary deficit
may be in the VMPFC, but the VMPFC could be com-
pensating for an underactive subcortical/striatal
response.
21,102The development of diffusion tensor imaging
studies might help to further understand the connections
between these different key brain areas.
Conclusions
Although it is difficult to disentangle the specific role of
anhedonia in major depressive disorder,imaging studies
have clearly shown that the severity of anhedonia is cor-
related,in depressed patients,with a deficit of activity of
the ventral striatum (reflecting decreased function of the
nucleus accumbens,probably as a primary event) and an
excess of activity of ventral region of the prefrontal cor-
tex (concerning an increased function of the VMPFC and
the orbitofrontal cortex, probably as a secondary phe-
nomenon).It is not yet possible to prove that the deficits
or excesses of activity are primary or secondary,but the
analyses of anhedonic nonclinical subjects,nonanhedo-
nic depressed patients,and depressed patients with vari-
ous levels of anhedonia seems to favor this way of think-
ing.This oversimplified way of assessing the role of two
major structures in anhedonia as a pivotal symptom of
depression also has to be confronted with the complex-
ity of the concept of anhedonia.Indeed,in order to get a
pleasurable,hedonic feeling,a large number of steps have
to be efficient, such as arousal (being able to globally
detect potentially rewarded stimuli),appraisal (having
the capacity to detect which specific stimuli are hedo-
nically relevant),and expression of this emotion (being
detected).The role of dopamine and the ventral striatum
in anhedonia,as a symptom of depression,is neverthe-
less a largely replicated finding;this does not mean that
they explain the trait,but more likely,that they are def-
initely involved…among others. ❏
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Mecanismos neurobiológicos de la
anhedonia
El término anhedonia se refiere a la disminución
de la capacidad de experimentar placer, y ha sido
estudiada en diferentes trastornos neuropsiquiá-
tricos. Sin embargo, la anhedonia se considera una
característica central del trastorno depresivo
mayor, de acuerdo con los criterios del DSM-IV para
depresión mayor y la definición del subtipo melan-
cólico, respecto a su capacidad para predecir la res-
puesta antidepresiva. Para evaluar la anhedonia se
han empleado mediciones conductuales, electrofi-
siológicas, hemodinámicas y otras basadas en
entrevistas y auto-reportes, pero los hallazgos más
interesantes se relacionan con estudios neurofar-
macológicos y neuroanatómicos. El análisis de suje-
tos no clínicos con anhedonia, de pacientes depre-
sivos sin anhedonia y de pacientes depresivos con
diferentes grados de anhedonia parecen favorecer
la hipótesis que postula que la gravedad de la
anhedonia se asocia con un déficit de actividad del
estriado ventral (incluyendo el núcleo accumbens)
y un exceso de actividad de la región ventral de la
corteza prefrontal (incluyendo la corteza prefron-
tal ventromedial y la corteza orbitofrontal), con un
papel central aunque no exclusivo de la dopamina. 
Mécanismes neurobiologiques de 
l’anhédonie
L’anhédonie est définie par une capacité diminuée
à éprouver du plaisir. Présente dans différents
troubles neuropsychiatriques, elle est néanmoins
considérée comme un symptôme clé de la dépres-
sion selon les critères DSM-IV de l’épisode dépres-
sif majeur, fait partie intégrante du caractère
mélancolique de l’épisode dépressif et est propo-
sée comme facteur prédictif de la réponse aux anti-
dépresseurs. L’anhédonie a été évaluée par des
mesures comportementales, électrophysiologiques,
hémodynamiques ainsi que par l’interrogatoire et
l’autoévaluation. Les résultats des études neuro-
pharmacologiques et neuroanatomiques sont
néanmoins les plus intéressants. L’analyse de sujets
anhédoniques non cliniques, de patients déprimés
nonanhédoniques et de patients déprimés ayant
des degrés variés d’anhédonie, est en faveur de
l’hypothèse d’une corrélation entre la sévérité de
l’anhédonie et un déficit de l’activité du striatum
ventral (noyau accumbens compris), un excès d’ac-
tivité de la région ventrale du cortex préfrontal
(cortex préfrontal ventromédian et cortex orbito-
frontal compris), et un rôle central, mais non exclu-
sif, de la dopamine.
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